Zura Bio Ltd
About Zura Bio Ltd
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$68.7M
- Total assets
- $113.9M
- Market cap
- $322.6M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $75.2M
- Operating income
- -$75.2M
- Net income
- -$68.7M
- EPS (basic)
- $-1.06
- EPS (diluted)
- $-1.06
Balance sheet
- Total assets
- $113.9M
- Current assets
- $112.3M
- Total liabilities
- $12.4M
- Current liabilities
- $12.4M
- Shareholders’ equity
- $101.5M
Cash flow
- Operating cash flow
- -$64.8M
- Investing cash flow
- -$113.0K
- Financing cash flow
- -$2.2M
- Net cash flow
- -$67.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $322.6M
- EPS (diluted)
- $-1.06
- Shares outstanding
- 91.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 21, 2023
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $68.7M.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Zura Bio Ltd.
Write a review
News about Zura Bio Ltd
News & sentiment via Polygon.io
